Abstract
Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Current Proteomics
Title: Systems Biology: Understanding Function from Genes to Networks
Volume: 6 Issue: 2
Author(s): Ravinder Singh and Rob Knight
Affiliation:
Abstract: Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Export Options
About this article
Cite this article as:
Singh Ravinder and Knight Rob, Systems Biology: Understanding Function from Genes to Networks, Current Proteomics 2009; 6(2) . https://dx.doi.org/10.2174/157016409788680974
DOI https://dx.doi.org/10.2174/157016409788680974 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Neuronal Expression of Junctional Adhesion Molecule-C is Essential for Retinal Thickness and Photoreceptor Survival
Current Molecular Medicine Efficacy of Yun Zhi (Coriolus versicolor) on Survival in Cancer Patients: Systematic Review and Meta-Analysis
Recent Patents on Inflammation & Allergy Drug Discovery Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) QSAR Studies of PTP1B Inhibitors: Recent Advances and Perspectives
Current Medicinal Chemistry Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design In Situ Gels Based Drug Delivery Systems
Current Drug Therapy In Vitro and In Vivo Transformations of Lutein
Mini-Reviews in Organic Chemistry Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation
Current Pharmaceutical Design Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology Extracellular Vesicles in the Treatment of Parkinson’s Disease: A Review
Current Medicinal Chemistry APO2L/TRAIL: New Insights in the Treatment of Autoimmune Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions
Current Pharmaceutical Design Bilski: Assessing the Impact of a Newly Invigorated Patent-Eligibility Doctrine on the Pharmaceutical Industry and the Future of Personalized Medicine
Current Topics in Medicinal Chemistry Modulation of the Immune Response by Targeting Endothelial Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism
Current Medicinal Chemistry Innate Immune System Modulation During Aging: Contributions of Macrophages and Dendritic Cells
Current Immunology Reviews (Discontinued) Novel Hybrid Compound 4-[(E)-2-phenylethenesulfonamido]-N-hydroxybutanamide with Antimetastatic and Cytotoxic Action: Synthesis and Anticancer Screening
Anti-Cancer Agents in Medicinal Chemistry Carotenoids in Photooxidative Stress
Current Nutrition & Food Science Inhibition of Angiogenesis by Non-Steroidal Anti-Inflammatory Drugs: From the Bench to the Bedside and Back
Current Drug Targets - Inflammation & Allergy Antidotes for Acute Cyanide Poisoning
Current Pharmaceutical Biotechnology